Background: Even after a complete work-up including thoracoscopic biopsies, a significant number of patients with pleural exudates are diagnosed with ‘non-specific pleuritis’, and no specific diagnosis can be made. The natural evolution of these patients is poorly understood. Objectives: To study the natural evolution of patients with non-specific pleuritis diagnosed after thoracoscopy and to evaluate whether the histological diagnosis of non-specific pleuritis corresponds with the clinical diagnosis of ‘idiopathic pleuritis’. Methods: We retrospectively studied the evolution of 75 patients between 1992 and 2002 (49 men and 26 women), mean (± SD) age 63.4 (± 13.3) years, who underwent diagnostic thoracoscopy because of an unexplained exudative pleural effusion, and in whom the histological diagnosis of non-specific pleuritis was made. Follow-up data were obtained through medical files and/or telephone contacts with general practitioners. Results: Of these 75 patients, 8.3% eventually developed a malignancy during the follow-up period. In the remaining patients (91.7%), the clinical evolution followed a benign course. Ultimately, a probable cause was established on clinical grounds in 40 patients. True idiopathic pleuritis was finally observed in 25% of patients with the histological diagnosis of non-specific pleuritis. Recurrence of the effusion occurred in 10 out of 60 (16.7%) patients, after a mean period of 26.2 months. Conclusions: The majority of non-specific pleuritis patients (91.7%) followed a benign course, with a spontaneous resolution of the effusion in 81.8% of cases. In the majority of patients, a probable cause of the pleuritis was identified. True ‘idiopathic benign pleuritis’ hence occurs in only a minority (25%) of patients.

Keywords:
Non-specific pleuritis, Thoracoscopy, Pleural effusion, Exudates
1.
Noppen M, De Waele M, Vandergucht K, et al: Volume and cellular content of pleural fluid in humans examined by pleural lavage. Am J Resp Crit Care Med 2000;162:1023–1026.
2.
Light RW: Pleural Diseases, ed 3. Baltimore, Williams & Wilkins, 1995, pp 7–17.
3.
Gharagozloo F, Read C, Wang K: Thoracoscopy in pleural effusion. J Bronchol 1996;3:209–216.
4.
Menzies R, Charbonneau M: Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 1991;114:271–276.
5.
Harris RJ, Kavuru MS, Mehta AC, et al: The impact of thoracoscopy on the management of pleural disease. Chest 1995;107:845–852.
6.
Blanc FX, Atassi K, Bignon J, et al: Diagnostic value of medical thoracoscopy in pleural disease. Chest 2002;121:1677–1683.
7.
Wilsher ML, Veale AG: Medical thoracoscopy in the diagnosis of unexplained pleural effusion. Respirology 1998;3:77–80.
8.
De Groot M, Walther G: Thoracoscopy in undiagnosed pleural effusions. S Afr Med J 1998;88:706–711.
9.
Ferrer JS, Munoz XG, Orriols RM, et al: Evolution of idiopathic pleural effusion. Chest 1996;109:1508–1513.
10.
Ryan CJ, Rodgers RF, Unni KK, et al: The outcome of patients with pleural effusion of indeterminate cause at thoracotomy. Mayo Clin Proc 1981;56:145–149.
11.
Kim NJ, Hong SC, Kim JO, et al: Etiologic considerations of nonspecific pleuritis. Korean J Intern Med 1991;6:58–63.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.